Protagen Protein Services GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Protagen Protein Services GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013522
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Protagen Protein Services GmbH (PPS), a subsidiary of Zukunftsfonds Heilbronn GmbH & Co KG is a contract research organization that concentrates on protein analytics. The organization offers services including protein characterization, services for biopharmaceuticals, biosimilars services and analytical methods. Its protein characterization services include protein quantification, protein primary structure, protein modification, bioassay and protein impurities. PPS’s services for biosimilars include detailed structural characterization and support in cell line and process development, among others. The organization partners with research institutes to offer its services to clients. It works in partnership with other pharmaceutical companies and research institutions. PPS is headquartered in Heilbronn, Germany.

Protagen Protein Services GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Protagen Protein Services, Assign International, Aurigon, Celonic and PharmaLex Form Joint Venture 9
Merger 10
Protagen Protein Services Merges with Panatecs 10
Acquisition 11
Zukunftsfonds Heilbronn Acquires Protagen Protein Services From Protagen 11
Protagen Protein Services GmbH – Key Competitors 12
Protagen Protein Services GmbH – Key Employees 13
Protagen Protein Services GmbH – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Protagen Protein Services, Assign International, Aurigon, Celonic and PharmaLex Form Joint Venture 9
Protagen Protein Services Merges with Panatecs 10
Zukunftsfonds Heilbronn Acquires Protagen Protein Services From Protagen 11
Protagen Protein Services GmbH, Key Competitors 12
Protagen Protein Services GmbH, Key Employees 13
Protagen Protein Services GmbH, Other Locations 14

★海外企業調査レポート[Protagen Protein Services GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shell Pakistan Ltd (SHEL):企業の財務・戦略的SWOT分析
    Summary Shell Pakistan Ltd (Shell Pakistan), a subsidiary of Royal Dutch Shell plc is an oil and gas company that markets petroleum products and compressed natural gas. The company operates through three segments such as retail, lubricants and aviation. It retail segment offers a range of fuels such …
  • Enerjisa Enerji AS:電力:M&Aディール及び事業提携情報
    Summary Enerjisa Enerji AS (Enerjisa Enerji) is a power generation company. The company operates in the business of distribution, and sale of electricity. It provides electricity wholesale and retail services, marketing, products and services development, energy management, and energy consultancy se …
  • Wellington Management Company LLP:企業のM&A・事業提携・投資動向
    Wellington Management Company LLP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wellington Management Company LLP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • SGS SA (SGSN):企業の財務・戦略的SWOT分析
    SGS SA (SGSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Tullow Oil plc:企業の戦略・SWOT・財務情報
    Tullow Oil plc - Strategy, SWOT and Corporate Finance Report Summary Tullow Oil plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Airborne Systems, Ltd.:企業の戦略・SWOT・財務情報
    Airborne Systems, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Airborne Systems, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Entreprise Tunisienne d’Activites Petrolieres:企業の戦略的SWOT分析
    Entreprise Tunisienne d'Activites Petrolieres - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • GOBARTO S.A.:企業の戦略・SWOT・財務分析
    GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report Summary GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Stantec Inc (STN):企業の財務・戦略的SWOT分析
    Stantec Inc (STN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Service Corporation International (SCI):企業の財務・戦略的SWOT分析
    Service Corporation International (SCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • TelaDoc Inc (TDOC):医療機器:M&Aディール及び事業提携情報
    Summary TelaDoc Inc (Teladoc) is a provider of telehealth services. The company offers short term prescription for amoxicillin, azithromycin, bactrim DS, augmentin, cipro, tessalon perles, flonase nasal spray, pyridium, prednisone and diflucan. It provides telehealth services for cold and flu sympto …
  • Enviva Partners LP (EVA):企業の財務・戦略的SWOT分析
    Enviva Partners LP (EVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Genetic Technologies Ltd (GTG)-医療機器分野:企業M&A・提携分析
    Summary Genetic Technologies Ltd (GTG) is a genetic tests company that offers testing products and services to assess sporadic breast cancer risk and cancer development, progression and management. It delivers the offerings by BREVAGen and BREVAGenplus tests. BREVAGen test enables the customers to a …
  • Baloise Holding Ltd:企業の戦略・SWOT・財務分析
    Baloise Holding Ltd - Strategy, SWOT and Corporate Finance Report Summary Baloise Holding Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CTD Holdings Inc (CTDH):企業の財務・戦略的SWOT分析
    Summary CTD Holdings Inc (CTDH), formerly Cyclodextrin Technologies Development Inc is a biotechnology company that develops, manufactures and distributes cyclodextrins products. The company’s products include aquaplex, trappsol and trappsol cyclo. It provides trappsol cyclo, which is a hydroxypropy …
  • McCarthy & Stone Plc:企業の戦略・SWOT・財務情報
    McCarthy & Stone Plc - Strategy, SWOT and Corporate Finance Report Summary McCarthy & Stone Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Euronet Worldwide, Inc.:企業の戦略・SWOT・財務分析
    Euronet Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report Summary Euronet Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • SREI Infrastructure Finance Ltd:企業のM&A・事業提携・投資動向
    SREI Infrastructure Finance Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SREI Infrastructure Finance Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Emerson Electric Co (EMR)-石油・ガス分野:企業M&A・提携分析
    Summary Emerson Electric Co. (Emerson) is a provider of infrastructure technologies and life cycle services for information and communication technology systems. The company offers hardware and software solutions for power, thermal and infrastructure management under the brands of Kop-Flex, jaure, a …
  • Seres Therapeutics Inc (MCRB):企業の財務・戦略的SWOT分析
    Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆